Two-year CBD research review shows significant positive impact on anxiety and stress

Analysis provides another tool for CBD business owners to educate their customers

There are many pressing questions about cannabidiol (CBD). How effective is it, how much should I take, what conditions will it help? A new study — the first meta-analysis by a nutritional supplements company on cannabinoids—sheds some light on those questions. 

The meta-analysis was produced by Nutrition Formulators, Inc. (NFI) of Miramar, Florida, and covered clinical papers worldwide from 2019 and 2020. The report was published in the peer-reviewed Innovare Journal of Medical Science in the November/December issue.

 

Anxiety & Stress 

In a review of 76 articles spanning the past two years, more than 70% of cannabidiol (CBD) research on anxiety and stress showed positive outcomes. The meta-analysis focused on CBD isolate and grouped the research into several categories, including CBD impacts on depression, sleep, panic attacks, dementia, inflammation, metabolism, behavior, Parkinson’s disease, and psychiatric illnesses. Human and animal studies were both included in the review.

“After spending 10 months reviewing the research, I was surprised at how many people with anxiety and depression could be helped by incorporating CBD into their lives, but I was also aware how important it is to do more research, especially on the impact of CBD on liver function,” said Dr. Marcelo Ferro, lead author and biochemist with Nutrition Formulators, Inc.

When looking at anxiety, the studies show that CBD reduces anticipator anxiety, such as speaking in public by affecting the part of the brain that processes emotional information. 

 

Depression

The analysis also showed a 66.6% positive improvement for clinicians using CBD as an alternative treatment for depression.

 

Dosage

One of the larger questions was how much CBD should be used. The dosing in the reports varied widely from 50mg to 600mg daily dosing. Also, much more research is needed on CBD’s side-effect impact on liver function as well as the how CBD interacts in the body. In addition, the study’s authors cited the need for larger population trials that would achieve a statistically significant measure.

“This is just a stepping-stone to understanding more about the amazing CBD compound, how it may be helpful to so many, but also what additional information we need to know so that people can use it as safely as possible. So many of our CBD business clients are looking for research-based information to educate their customers, this report is a step in that direction,” said Adolfo Graubard, Nutrition Formulators, Inc. ​ Chief Executive Officer.

NFI is currently working on additional CBD studies focusing on neuroinflammation and autism in partnership with several research institutions. 

You can access the report at https://innovareacademics.in/journals/index.php/ijms/article/view/39501

 

To stay connected on the latest information regarding dietary supplements and CBD, please visit Nutrition Formulators Inc. and follow along on social media at @NutritionFormulators on Instagram, LinkedIn, and Twitter

 

About Nutrition Formulators 

Nutrition Formulators Inc. (NFI) is a leading manufacturer of nutraceutical products, specializing in private label & contract manufacturing of custom formulas. As a family-owned and performance-driven business, NFI's mission is to help entrepreneurs create the world's best supplement brands and to educate consumers on navigating the health industry. Founded in 1997, NFI has continuously delivered on its commitment to creating safe and effective nutraceutical products for hundreds of clients. Each step of NFI's manufacturing process is aligned with the CRF 21 Part 111 regulations. Their cGMP-certified facility is located in Miramar Florida. For information on Nutrition Formulators Inc. research, marketing and manufacturing please call the NFI Service Center at (954)272-2220 or visit www.NutritionFormulators.com.

 

 

Share

Latest stories

Campos Foundation to Give Underrepresented Students a Once-in-a-Lifetime Broncos Sideline Experience
Denver, CO – The Campos Foundation is making dreams come true for 25 underrepresented students and their parents on Sunday, December 15, 2024, by taking them to a Denver Broncos game—and giving them exclusive sideline access. For many of these students, it will be their first time experiencing a professional sporting event, marking an unforgettable milestone. The Campos Foundation is the Denver Broncos' official STEM Education Partner. This special day is part of the Foundation’s commitment to inspiring underrepresented minority and female students to pursue careers in STEM (Science, Technology, Engineering, and Math). Since its establishment in 2015, the Campos Foundation has awarded over $6 million in scholarships to local students, providing life-changing educational opportunities and mentorship.
newsroom.mandccommunications.com
Website preview
Website preview
Vita Brevis Fine Art Honors “Superhero” Volunteers, Local Pediatric Patients, and their Families for a Fun-Filled Portrait Session
This free event aims to give back to volunteers by recognizing their work with an unforgettable, professional photography experience
newsroom.mandccommunications.com

Get updates in your mailbox

By clicking "Subscribe" I confirm I have read and agree to the Privacy Policy.

About M&C Communications

For over 15 years, M&C Communications has proven to be an expert in Insider Media Relations™ and Brand Protection PR™, providing businesses with strategic public relations plans and effective content creation services. M&C Communications helps companies enhance visibility and achieve marketing objectives while maintaining brand resiliency. For more information, visit mandccommunications.com.

Contact

720.273.0927

dmulligan@mandccommunications.com

mandccommunications.com